Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Trial of Pimavanserin in Dementia-Related Psychosis.
Journal: The New England journal of medicine
Published: July 21, 2021
Development and assessment of a brief screening tool for psychosis in dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: July 08, 2021
Relapse in Dementia-related Psychosis and Clinical Decisions.
Journal: Alzheimer disease and associated disorders
Published: June 29, 2021
Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis.
Journal: International journal of geriatric psychiatry
Published: January 30, 2020
A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.
Journal: Neurobiology of aging
Published: October 10, 2019
Pimavanserin: Potential Treatment For Dementia-Related Psychosis.
Journal: The journal of prevention of Alzheimer's disease
Published: October 10, 2018
EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis.
Journal: Clinical EEG and neuroscience
Published: January 11, 2016
TWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity.
Journal: PloS one
Published: July 29, 2015
TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy.
Journal: Human molecular genetics
Published: December 16, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026